236 related articles for article (PubMed ID: 17640920)
1. Epigenetic silencing of a Ca(2+)-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers.
Jin H; Wang X; Ying J; Wong AH; Cui Y; Srivastava G; Shen ZY; Li EM; Zhang Q; Jin J; Kupzig S; Chan AT; Cullen PJ; Tao Q
Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12353-8. PubMed ID: 17640920
[TBL] [Abstract][Full Text] [Related]
2. The GAP1 family of GTPase-activating proteins: spatial and temporal regulators of small GTPase signalling.
Yarwood S; Bouyoucef-Cherchalli D; Cullen PJ; Kupzig S
Biochem Soc Trans; 2006 Nov; 34(Pt 5):846-50. PubMed ID: 17052212
[TBL] [Abstract][Full Text] [Related]
3. An expanding role for RAS GTPase activating proteins (RAS GAPs) in cancer.
Maertens O; Cichowski K
Adv Biol Regul; 2014 May; 55():1-14. PubMed ID: 24814062
[TBL] [Abstract][Full Text] [Related]
4. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers.
Conway KE; McConnell BB; Bowring CE; Donald CD; Warren ST; Vertino PM
Cancer Res; 2000 Nov; 60(22):6236-42. PubMed ID: 11103776
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of RAS protein activator like-1 in gastric cancer.
Seto M; Ohta M; Ikenoue T; Sugimoto T; Asaoka Y; Tada M; Mohri D; Kudo Y; Ijichi H; Tateishi K; Otsuka M; Hirata Y; Maeda S; Koike K; Omata M
Int J Cancer; 2011 Mar; 128(6):1293-302. PubMed ID: 20473946
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Ras GTPase-activating protein regulated by receptor-mediated Ca2+ oscillations.
Walker SA; Kupzig S; Bouyoucef D; Davies LC; Tsuboi T; Bivona TG; Cozier GE; Lockyer PJ; Buckler A; Rutter GA; Allen MJ; Philips MR; Cullen PJ
EMBO J; 2004 Apr; 23(8):1749-60. PubMed ID: 15057271
[TBL] [Abstract][Full Text] [Related]
7. Studying the spatial and temporal regulation of Ras GTPase-activating proteins.
Kupzig S; Bouyoucef D; Cozier GE; Cullen PJ
Methods Enzymol; 2006; 407():64-82. PubMed ID: 16757315
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression.
Ohta M; Seto M; Ijichi H; Miyabayashi K; Kudo Y; Mohri D; Asaoka Y; Tada M; Tanaka Y; Ikenoue T; Kanai F; Kawabe T; Omata M
Gastroenterology; 2009 Jan; 136(1):206-16. PubMed ID: 18992247
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of Betaig-h3 gene in human cancer cells.
Shao G; Berenguer J; Borczuk AC; Powell CA; Hei TK; Zhao Y
Cancer Res; 2006 May; 66(9):4566-73. PubMed ID: 16651406
[TBL] [Abstract][Full Text] [Related]
10. LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer.
Wu G; Guo Z; Chang X; Kim MS; Nagpal JK; Liu J; Maki JM; Kivirikko KI; Ethier SP; Trink B; Sidransky D
Cancer Res; 2007 May; 67(9):4123-9. PubMed ID: 17456585
[TBL] [Abstract][Full Text] [Related]
11. Specific biochemical inactivation of oncogenic Ras proteins by nucleoside diphosphate kinase.
Fischbach MA; Settleman J
Cancer Res; 2003 Jul; 63(14):4089-94. PubMed ID: 12874011
[TBL] [Abstract][Full Text] [Related]
12. The role of promoter hypermethylation in fibroblast activation and fibrogenesis.
Zeisberg EM; Zeisberg M
J Pathol; 2013 Jan; 229(2):264-73. PubMed ID: 23097091
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility.
Xia M; Land H
Nat Struct Mol Biol; 2007 Mar; 14(3):215-23. PubMed ID: 17310253
[TBL] [Abstract][Full Text] [Related]
14. VEGF receptor expression and signaling in human bladder tumors.
Wu W; Shu X; Hovsepyan H; Mosteller RD; Broek D
Oncogene; 2003 May; 22(22):3361-70. PubMed ID: 12776187
[TBL] [Abstract][Full Text] [Related]
15. A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity.
Kolfschoten IG; van Leeuwen B; Berns K; Mullenders J; Beijersbergen RL; Bernards R; Voorhoeve PM; Agami R
Cell; 2005 Jun; 121(6):849-58. PubMed ID: 15960973
[TBL] [Abstract][Full Text] [Related]
16. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis.
Wang Y; Li J; Cui Y; Li T; Ng KM; Geng H; Li H; Shu XS; Li H; Liu W; Luo B; Zhang Q; Mok TS; Zheng W; Qiu X; Srivastava G; Yu J; Sung JJ; Chan AT; Ma D; Tao Q; Han W
Cancer Res; 2009 Jun; 69(12):5194-201. PubMed ID: 19509237
[TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas.
Byun DS; Cho K; Ryu BK; Lee MG; Kang MJ; Kim HR; Chi SG
Cancer Res; 2003 Nov; 63(21):7068-75. PubMed ID: 14612497
[TBL] [Abstract][Full Text] [Related]
19. Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid).
Blum R; Elkon R; Yaari S; Zundelevich A; Jacob-Hirsch J; Rechavi G; Shamir R; Kloog Y
Cancer Res; 2007 Apr; 67(7):3320-8. PubMed ID: 17409441
[TBL] [Abstract][Full Text] [Related]
20. Real-time in vitro measurement of intrinsic and Ras GAP-mediated GTP hydrolysis.
Shutes A; Der CJ
Methods Enzymol; 2006; 407():9-22. PubMed ID: 16757310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
